Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes.

MLA

Peero, Einav Kadour, et al. “Intravenous Immunoglobulin for Patients with Unexplained Recurrent Implantation Failure: A 6-Year Single Center Retrospective Review of Clinical Outcomes.” Scientific Reports, vol. 14, no. 1, Feb. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41598-024-54423-z.

APA

Peero, E. K., Banjar, S., Khoudja, R., Ton-leclerc, S., Beauchamp, C., Benoit, J., Beltempo, M., Dahan, M. H., Gold, P., Kadoch, I. J., Jamal, W., Laskin, C., Mahutte, N., Phillips, S., Sylvestre, C., Reinblatt, S., Mazer, B. D., Buckett, W., & Genest, G. (2024). Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes. Scientific Reports, 14(1), 1–11. https://doi.org/10.1038/s41598-024-54423-z

Chicago

Peero, Einav Kadour, Shorooq Banjar, Rabea Khoudja, Shaonie Ton-leclerc, Coralie Beauchamp, Joanne Benoit, Marc Beltempo, et al. 2024. “Intravenous Immunoglobulin for Patients with Unexplained Recurrent Implantation Failure: A 6-Year Single Center Retrospective Review of Clinical Outcomes.” Scientific Reports 14 (1): 1–11. doi:10.1038/s41598-024-54423-z.